Question: What is the WHO is recommendation for use of corticosteroids for treating COVID-19

Answer passage (source: WHO):
page_title: Q&A: HIV, antiretrovirals and COVID-19
section_headers: What is WHO’s position on use of corticosteroids for the treatment of COVID-19?
section_content: The current interim guidance from WHO on clinical management of severe acute
respiratory infection when COVID-19 infection is suspected advises against the
use of corticosteroids unless indicated for another reason.[8]
This guidance is based on several systematic reviews that cite lack of
effectiveness and possible harm from routine treatment with corticosteroids
for viral pneumonia or acute respiratory distress syndrome.[9]

Reviewer feedback on this answer:
Answers the question but does not give any references or links.
Provides a succinct answer but including links to the evidence [9] (for example) would be helpful.

Reviewer ratings:
Acceptable
Acceptable

Answer passage (source: WHO):
page_title: Q&A: Malaria and COVID-19
section_headers: What is WHO’s position on the use of Artemisia plant material for the prevention or treatment of malaria and/or COVID-19?
section_content: The most widely used antimalarial treatments, artemisinin-based combination
therapies (ACTs), are produced using the pure artemisinin compound extracted
from the plant Artemisia annua. In recent years, some news reports have
suggested that a range of non-pharmaceutical products made from Artemisia
plant material – such as herbal teas and tablets – may be effective in
preventing or treating malaria. Now, there are reports that products made from
Artemisia plant material may also have a preventive or curative effect on
COVID-19.
WHO urges extreme caution over reports touting the efficacy of such products.
As explained in a WHO position statement, there is no
scientific evidence base to support the use of non-pharmaceutical forms of
Artemisia for the prevention or treatment of malaria. There is also no
evidence to suggest that COVID-19 can be prevented or treated with products
made from Artemisia -based plant material.

Reviewer feedback on this answer:
Does not mention the cortocosteriods mentioned in the question at all
The questions is about corticosteroids but the answer is about malaria treatments not corticosteroids specifically.

Reviewer ratings:
Bad
Bad

Answer passage (source: WHO):
page_title: Q&A: Malaria and COVID-19
section_headers: What is WHO’s position on the use of chloroquine and hydroxychloroquine in the context of the COVID-19 response?
section_content: WHO is actively following the ongoing clinical trials that are being conducted
in response to COVID-19, including studies looking at the use of chloroquine
and its derivative, hydroxychloroquine, for treatment and/or prevention.
Currently, there is insufficient data to assess the efficacy of either of
these medicines in treating patients with COVID-19, or in preventing them from
contracting the coronavirus.
In the context of the COVID-19 response, hydroxychloroquine was one of the
potential treatment options that was being assessed as part of the Solidarity
clinical trial. However, on 25 May 2020, the WHO Director-General
announced that the Executive Group of the Solidarity Trial had put a
temporary pause on the hydroxychloroquine arm
of the trial while the safety data are reviewed. This decision follows the
publication of a recent Lancet study focusing on the effects of
hydroxychloroquine on COVID-19 patients who have been hospitalized; authors of
the study reported a higher mortality rate among patients who received the
drug. The Director-General made clear in his announcement that
hydroxychloroquine continues to be a safe drug for use in patients with
malaria and autoimmune diseases.
For public health emergencies, WHO has a systematic and transparent process
for research and development (R&D), including for clinical trials of drugs.
The WHO “R&D Blueprint” for COVID-19,
initiated on 7 January 2020, aims to fast-track the availability of effective
tests, vaccines and medicines that can be used to save lives and avert large-
scale crises. WHO has also designed a set of procedures to assess the
performance, quality and safety of medical technologies during emergency
situations.  

Reviewer feedback on this answer:
Does not address the question about cortocosteriods.
The question is about corticosteroids and the article does not make clear that cholorquine and it's derivative are corticosteroids or not.

Reviewer ratings:
Bad
Could be Improved